Content Block Tag: NRG-BR008: HERO

‘Text/HTML’ of page ‘NRG-BR008: HERO’

Am I eligible for this study? Women who have low-risk, HER2-positive breast cancer, have undergone breast-conserving surgery (e.g., lumpectomy), and have had chemotherapy and HER2-targeted therapy are eligible to participate in the HERO study. Your healthcare team is the best source for information about your treatment options, including cancer clinical trials. Be sure to take […]

‘Text/HTML’ of page ‘NRG-BR008: HERO’

About This Study NRG-BR008, also known as the “HERO” trial, is a clinical study trying to determine if treatment with HER2-targeted therapy without radiation therapy is as good as the usual treatment of HER2-targeted therapy with radiation in patients with early-stage HER2-positive breast cancer. We are doing this study because we want to find […]

‘Text/HTML’ of page ‘NRG-BR008: HERO’

Clinical Studies FAQ

‘Text/HTML’ of page ‘NRG-BR008: HERO’

The NRG-BR008 HERO Study FAQ